SPDR S&P Biotech ETF $XBI Shares Acquired by Garda Capital Partners LP

Garda Capital Partners LP increased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 56.9% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 22,552 shares of the exchange traded fund’s stock after acquiring an additional 8,176 shares during the period. Garda Capital Partners LP’s holdings in SPDR S&P Biotech ETF were worth $1,829,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the company. JPMorgan Chase & Co. boosted its position in SPDR S&P Biotech ETF by 625.1% during the 1st quarter. JPMorgan Chase & Co. now owns 10,369,706 shares of the exchange traded fund’s stock worth $840,983,000 after acquiring an additional 12,344,558 shares during the period. Goldman Sachs Group Inc. boosted its position in SPDR S&P Biotech ETF by 33.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 13,524,858 shares of the exchange traded fund’s stock worth $1,096,866,000 after acquiring an additional 3,353,029 shares during the period. Simplex Trading LLC increased its stake in SPDR S&P Biotech ETF by 116.1% during the 1st quarter. Simplex Trading LLC now owns 241,039 shares of the exchange traded fund’s stock valued at $19,548,000 after buying an additional 1,741,445 shares during the period. BlueCrest Capital Management Ltd acquired a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $138,051,000. Finally, RA Capital Management L.P. acquired a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $110,615,000.

SPDR S&P Biotech ETF Trading Down 0.5%

SPDR S&P Biotech ETF stock opened at $90.21 on Tuesday. The stock has a market cap of $4.91 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. The company’s 50-day moving average price is $85.70 and its two-hundred day moving average price is $83.88. SPDR S&P Biotech ETF has a 52 week low of $66.66 and a 52 week high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.